Phase I trial of 57-57 (paquinimod) in patients with systemic lupus erythematosus.

Trial Profile

Phase I trial of 57-57 (paquinimod) in patients with systemic lupus erythematosus.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Nov 2011

At a glance

  • Drugs Paquinimod (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Nov 2011 Results published in Arthritis and Rheumatism.
    • 17 Sep 2010 New trial record
    • 16 Sep 2010 An update on this trial will be presented at the UBS Global Life Sciences Conference, September 2010, according to an Active Biotech media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top